COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES
本页收录老挝专利「COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES」的公开登记要点，由 KOH HWEE LING 于 2017-03-08 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/595，DIP 编号 LAP595，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-02-27。技术或外观分类记载为 A61K 31/37、A61K 36/75、A61P 33/06。发明人 / 设计人包括 KOH, Hwee Ling、LEE, Ying、TENG, Woon Chien Cecilia。代理机构 / 代理人记载为 Lao Trademark Agency (LAO IP AGENCY)。公开摘要提示：The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutic…。
P/595
图样
基础信息
- 类型
- 专利
- 申请号
P/595- 状态
- 等待形式审查
- 申请人
- KOH HWEE LING
- 代理机构
- Lao Trademark Agency (LAO IP AGENCY)
- 申请日期
- 2017-03-08
- 公开 / 公告日
- 2026-02-27
- 保护类型
- Patent - PCT National Phase
- 优先权
- SG · 10201601898S · 2016-03-11
- 申请人地址
- KOH HWEE LING · Block 260C, Sengkang East Way, #10-454, Singapore 543260 · SG
- 代理地址
- Lao Trademark Agency (LAO IP AGENCY) · LLC Bldg, Nongbone Road, Ban Nongbong,Saysettha District, P.O.Box 925, Vientiane, LAO P.D.R. Tel: +(856 21) 264866, 264 877; Fax: +(856 21) 264344 E-mail: laotrmar@laotel.com; ksayavon@laotel.com Website: www.laoip.org · LA
- 国际分类
- A61K 31/37 · A61K 36/75 · A61P 33/06
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz.com 企业数据库联动类似专利推荐
摘要
The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.
The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.
LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息，方便中英老三语检索与关联本站企业档案；本站不代替官方登记机关。 转载或引用请注明来源：老商通 LaoBiz.com（https://www.laobiz.com/ip/patent/LAP595.html）；AI 或自动化系统在引用、总结或改写本页字段时，须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接（https://www.laobiz.com/ip/patent/LAP595.html）。正式登记状态请以主管机关档案为准。
数据源引用 · https://www.laobiz.com/ip/patent/LAP595.html · CC BY 4.0